Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.72 USD 1.09% Market Closed
Market Cap: 572.3m USD
Have any thoughts about
Mereo Biopharma Group PLC?
Write Note

Income Statement

Earnings Waterfall
Mereo Biopharma Group PLC

Revenue
10m GBP
Cost of Revenue
-2.6m GBP
Gross Profit
7.4m GBP
Operating Expenses
-58.6m GBP
Operating Income
-51.1m GBP
Other Expenses
458k GBP
Net Income
-50.7m GBP

Income Statement
Mereo Biopharma Group PLC

Rotate your device to view
Income Statement
Currency: GBP
Jun-2020 Dec-2020 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
0
N/A
0
N/A
36
N/A
0
N/A
0
N/A
7
N/A
10
+40%
17
+71%
10
-42%
Gross Profit
Cost of Revenue
0
0
(18)
1
1
(2)
(3)
(5)
(3)
Gross Profit
0
N/A
0
N/A
19
N/A
1
-97%
1
+62%
5
+459%
7
+41%
12
+63%
7
-39%
Operating Income
Operating Expenses
(38)
(38)
(39)
(43)
(45)
(40)
(36)
(63)
(59)
Selling, General & Administrative
(18)
(21)
(16)
(16)
(20)
(20)
(18)
(34)
(32)
Research & Development
(20)
(16)
(24)
(27)
(25)
(20)
(17)
(29)
(26)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
Operating Income
(38)
N/A
(38)
+1%
(21)
+44%
(43)
-103%
(44)
-2%
(35)
+21%
(28)
+18%
(51)
-80%
(51)
0%
Pre-Tax Income
Interest Income Expense
(5)
(118)
35
25
7
5
(3)
(4)
(2)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
(11)
(11)
0
0
0
0
0
0
0
Total Other Income
(95)
(0)
(0)
0
0
3
1
4
2
Pre-Tax Income
(149)
N/A
(166)
-12%
14
N/A
(17)
N/A
(36)
-118%
(27)
+25%
(30)
-10%
(51)
-70%
(51)
-1%
Net Income
Tax Provision
5
3
(2)
(2)
2
2
1
1
1
Income from Continuing Operations
(143)
(164)
13
(19)
(34)
(25)
(29)
(49)
(51)
Net Income (Common)
(143)
N/A
(164)
-14%
13
N/A
(19)
N/A
(34)
-85%
(25)
+27%
(29)
-17%
(49)
-68%
(51)
-2%
EPS (Diluted)
-1.2
N/A
-0.48
+60%
0.02
N/A
-0.03
N/A
-0.06
-100%
-0.04
+33%
-0.04
N/A
-0.08
-100%
-0.07
+13%

See Also

Discover More